You are here

Bioiberica to present new active ingredients of animal origin at CPhI Worldwide

10 Oct 2018
  • Thyroid extract, trypsin and calcium heparin, among the new products of Bioiberica’s Human Health Area portfolio
  • CPhl Worldwide is one of the most important and influential events for the world’s chemical and pharmaceutical industry

Bioiberica confirms, once again, their presence at CPhI Worldwide, the most important event for producers of pharmaceutical ingredients and solutions. At this year’s edition, held 9 – 11 October in Madrid, Spain, the exhibition will be attended by more than 2500 exhibitors from 150 countries as well as more than 45,000 professionals of the pharmaceutical sector.

At booth 14.0F40, Bioiberica’s Heparin Science and Health Care Divisions will be presenting new animal-derived APIs. These include thyroid extract (rich in T-3 and T-4 hormones and obtained through natural methods) and calcium heparin, as well as other biological products currently under development, such as trypsin and others. 

Bioiberica is a pharmaceutical company of global reach, specializing in the identification and extraction of biomolecules of animal origin of high biological and therapeutic value for the pharma and nutraceutical industry. It is a world leader in the production of the pharmaceutical-grade active ingredient of heparin. Their large portfolio also includes sodium, lithium, calcium and ammonic heparin, dermatan sulfate, heparan sulfate, and heparinoids. 

The company is also a leader in pharmaceutical-grade active ingredients and finished products for joint health and mobility, such as chondroitin sulfate, glucosamine, hyaluronic acid and native collagen. More precisely, this year stands out b-2Cool®, a natural ingredient which helps maintain joint health thanks to its immune mediated mechanism of action. And, among the finished products portfolio, the highlight will be Hialsorb® Intraarticular, an injectable hyaluronic acid.

For Bioiberica, this event represents a unique occasion to identify business opportunities and forge new partnerships. It also provides a unique occasion to learn about the latest market trends and developments.

Related News

4 May 2023

They've set up Biovall Heparin Science, a joint pharmaceutical innovation project with an investment of 25 million euros and 20 skilled jobs

28 Apr 2023

Join Bioiberica at stand F130 in Geneva, 9-11 May to discover the company’s latest science and insights driving innovation in the nutraceuticals market.